Last reviewed · How we verify
NCT07114848
Comparing Tamsulosin and Solifenacin for Relieving Double J Stent Symptoms: Using the USSQ.
Phase 4 trial testing Tamsulosin in Ureteral Stent-Related Symptom in 60 participants. Completed in 30 March 2025.
30 December 2024
Quick facts
| Lead sponsor | Liaquat National Hospital & Medical College |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 13 June 2024 |
| Primary completion | 30 December 2024 |
| Estimated completion | 30 March 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Tamsulosin (tamsulosin) — full drug profile →
- solifenacin (SOLIFENACIN) — full drug profile →
Conditions studied
- Ureteral Stent-Related Symptom — all drugs for Ureteral Stent-Related Symptom →
- Alpha Blocker — all drugs for Alpha Blocker →
- Anticholinergics — all drugs for Anticholinergics →
- Ureter Calculi — all drugs for Ureter Calculi →
Sponsor
Liaquat National Hospital & Medical College
Who can join
Adults 20 to 50, any sex, with Ureteral Stent-Related Symptom or Alpha Blocker. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the effects of two medications-tamsulosin and solifenacin-on symptoms associated with double J (DJ) ureteral stents. The research is conducted among patients undergoing unilateral DJ stent placement for ureteric calculi or post-ureteroscopic lithotripsy. Participants are randomly assigned to receive either tamsulosin or solifenacin, and symptom severity is assessed using the Ureteral Stent Symptom Questionnaire (USSQ).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07114848
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Tamsulosin
Trials testing the same drug.
- NCT07467343 — Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial · Phase 4 · not yet recruiting
- NCT07310797 — Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion · Phase 4 · not yet recruiting
- NCT06966804 — Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms · Phase 3 · recruiting
- NCT06843538 — Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery · Phase 3 · recruiting
- NCT05401032 — Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH. · Phase 2 · recruiting
Other recruiting trials for Ureteral Stent-Related Symptom
Currently open trials in the same condition.
- NCT06803030 — Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms · Phase 3 · recruiting
Other Liaquat National Hospital & Medical College trials
Trials by the same sponsor.
- NCT07416084 — Comparison of Hypotension After Spinal Anesthesia With Hyperbaric Vs Isobaric Bupivacaine in Elective Cesarean After Col · Phase 2 · not yet recruiting
- NCT07180095 — Children of Age 2-6years Undergoing Elective Surgery Will be Divided Into Two Groups Randomly. This Study Aims to Evalua · Phase 1, PHASE2 · not yet recruiting
- NCT07482709 — Comparison Between Tranversus Abdominis Plane (TAP) Block With Only Bupivacaine and TAP Block With Bupivacaine Plus Keta · Phase 1, PHASE2 · recruiting
- NCT07234396 — Animated Video and Associated Pain and Anxiety Reduction, Following Pin Removal Post-supracondylar Fracture Fixation · NA · recruiting
- NCT07234370 — Distal Radial Fractures in Adult Patients: 4 Weeks Versus 6 Weeks of Cast Immobilization · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07114848 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Liaquat National Hospital & Medical College
- Last refreshed: 11 August 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07114848.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing